← back to search

Shifeng Huang

Dalian Medical University · CN
Area of research
Molecular Medicine · Pharmacology
Research interest
Research focused on Mesenchymal stem cell and microRNA, with related work in Cell biology, Cancer research, Pathogenesis. Notable publications include 'Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis', 'A pH-Triggered, Self-Assembled, and Bioprintable Hybrid Hydrogel Scaffold for Mesenchymal Stem Cell Based Bone Tissue Engineering', and 'Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway'.
h-index
citations
2,069
works
10
NIH funding
primary concept
email

Recent publications

A pH-Triggered, Self-Assembled, and Bioprintable Hybrid Hydrogel Scaffold for Mesenchymal Stem Cell Based Bone Tissue Engineering
ACS Applied Materials & Interfaces 2019cited by 157position: middledoi
A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells
Cancer Gene Therapy 2019cited by 57position: middledoi
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Genes & Diseases 2018cited by 1,480position: middledoi
Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway
Scientific Reports 2018cited by 83position: middledoi
Thermoresponsive Citrate-Based Graphene Oxide Scaffold Enhances Bone Regeneration from BMP9-Stimulated Adipose-Derived Mesenchymal Stem Cells
ACS Biomaterials Science & Engineering 2018cited by 77position: middledoi
BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells
Laboratory Investigation 2018cited by 77position: middledoi
A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions
Molecular Therapy — Nucleic Acids 2018cited by 45position: middledoi
Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells
Cellular Physiology and Biochemistry 2018cited by 38position: middledoi
Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)
Genes & Diseases 2018cited by 32position: middledoi
The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs
Genes & Diseases 2018cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yixiao Feng · Dalian Medical University2 papers (2018–2018)Wenping Luo · Southwest University2 papers (2018–2018)Bo Huang · Chongqing University2 papers (2018–2018)Bo Liu · Beijing YouAn Hospital2 papers (2018–2018)Linghuan Zhang · Dalian Medical University2 papers (2018–2018)Xiaojuan Ji · Anhui Medical University2 papers (2018–2018)Hue H. Luu · University of Chicago Medical Center2 papers (2018–2018)Zongyue Zeng · Brown University2 papers (2018–2018)Rex C. Haydon · University of Chicago2 papers (2018–2018)Jiayan Lei · Xiamen University1 papers (2018–2018)Lei Yan · Shandong University1 papers (2018–2018) · 1 papers (2018–2018)Wei Liu · Xuchang University1 papers (2018–2018)Xi Wang · Hebei Medical University1 papers (2018–2018)Guosheng Ren · Molecular Oncology (United States)1 papers (2018–2018)Liqun Chen · Shandong University1 papers (2018–2018)Yi Shu · University of Iowa1 papers (2018–2018) · 1 papers (2018–2018)Chen Zhao · Southern Medical University1 papers (2018–2018)Ruyi Zhang · Fudan University1 papers (2018–2018)